Document is current

Article History

Received: 10 January 2025

Accepted: 4 April 2025

First Online: 21 April 2025

Declarations

:

: Eduard Valmaseda-Castellón, Rui Figueiredo and Octavi Camps-Font have received research funding and honoraria from AVINENT (Santpedor, Spain), and research funding from NOBEL BIOCARE (Kloten, Switzerland). Both companies manufacture and sell clear aligners. Cristina de-la-Rosa-Gay has no relevant conflicts of interest. The authors also want to declare the following conflicts of interest outside the submitted work:Eduard Valmaseda-Castellón, Rui Figueiredo and Octavi Camps-Font have received research funding and honoraria from AVINENT (Santpedor, Spain), and research funding from NOBEL BIOCARE (Kloten, Switzerland). Both companies manufacture and sell clear aligners. Cristina de-la-Rosa-Gay has no relevant conflicts of interest. The authors also want to declare the following conflicts of interest outside the submitted work: Dr. Eduard Valmaseda-Castellón reports grants, personal fees, and non-financial support from MozoGrau (Valladolid, Spain), Inibsa Dental (Lliçà de Vall, Spain), Dentaid SL (Cerdanyola del Vallés, Spain), and personal fees from Laboratorios Silanes (Mexico city, Mexico) outside the submitted work. Dr. Eduard Valmaseda-Castellón has also participated as a principal investigator in a randomized clinical trial sponsored by Geistlich Pharma AG (Wolhusen, Switzerland) and in other clinical trials as a sub-investigator for Mundipharma (Cambridge, UK). Dr. Octavi Camps-Font reports grants and non-financial support from Inibsa Dental (Lliçà de Vall, Spain) and Dentaid SL (Cerdanyola del Vallés, Spain) outside the submitted work.